Literature DB >> 9354475

Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation.

M F Bachmann1, K McKall-Faienza, R Schmits, D Bouchard, J Beach, D E Speiser, T W Mak, P S Ohashi.   

Abstract

Efficient T cell activation requires the engagement of a variety of ligand/receptor molecules in addition to T cell receptor (TCR)-major histocompatibility complex (MHC)/peptide interactions. The leukocyte function antigen 1 (LFA-1) and the CD28 glycoprotein have both been implicated in T cell activation. The present study dissects the roles of LFA-1 and CD28 in the activation of naive virus-specific CD8+ T cells. We demonstrate that LFA-1 facilitates T cell activation by lowering the amounts of antigen necessary for T cell activation. In the absence of LFA-1, 100-fold more antigen was required for T cell-antigen-presenting cell (APC) conjugation and all subsequent events of T cell activation, including TCR down-regulation, Ca2+-flux, T cell proliferation, and lytic effector cell induction. Thus, LFA-1 facilitates the functional triggering of TCRs by promoting adhesion of T cells to APCs but does not affect T cell activation otherwise. In contrast, CD28 played an entirely different role during T cell activation. CD28 reduced the number of TCRs that had to be triggered for T cell activation and allowed activation of T cells by low affinity ligands. CD28 but not LFA-1 prevented induction of T cell unresponsiveness after stimulation of TCRs. These results demonstrate that LFA-1 and CD28 exhibit distinct, nonoverlapping ways to influence T cell activation and suggest that the terms costimulation and signal 2 should be revisited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354475     DOI: 10.1016/s1074-7613(00)80376-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  120 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Local immune responses in afferent and efferent lymph.

Authors:  D M Haig; J Hopkins; H R Miller
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

Review 3.  Imaging T-cell antigen recognition and comparing immunological and neuronal synapses.

Authors:  E Donnadieu; P Revy; A Trautmann
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

4.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

6.  Cooperative enhancement of specificity in a lattice of T cell receptors.

Authors:  C Chan; A J George; J Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

7.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 8.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

9.  Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro.

Authors:  Chuda Chittasupho; Joshua Sestak; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Mol Pharm       Date:  2013-12-04       Impact factor: 4.939

10.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.